Overview

Focus on companies with proven products, and processes seeking expansion capital in order to grow operations and achieve a return for investors upon eventual sale or IPO. Acorn has Invested more than $1B AUD into ASX listed primary market opportunities, typically in development and growth situations.

RAM and its partner Acorn Capital have made 11 investments in portfolio companies since 2017. 5 of those companies have since either been listed or sold via trade sale, generating strong returns for our investors. All investments have been made through Australian Venture Capital Limited Partnerships (VCLP), which are also complying significant investments for the VCPE component of the Significant Investor Visa (SIV) program.

Select high quality Australian companies that are at the expansion stage of development

Focus on extensive research and due diligence to identify companies with differentiated product and services

Excludes property development, finance and construction

Australia’s first and largest specialist small company investment manager with a $1.4 billion AUD in funds under management

Estimated aggregate annualised IRR on unlisted investments is 30% p.a.

The average duration of unlisted investments is approximately 2.6 years*

Fund Information

1 MONTH 2 MONTHS 3 MONTHS 6 MONTHS 1 YEAR 2 YEAR P.A. SINCE INCEPTION (TOTAL) INCEPTION DATE
ACORN CAPITAL PRIVATE OPPORTUNITIES FUND L.P. -20.23% -24.15% -23.24% -0.30% 68.00% 35.60% 22.45% DEC 16
ACORN CAPITAL PRIVATE OPPORTUNITIES FUND L.P.
1 MONTH -20.23%
2 MONTHS -24.15%
3 MONTHS -23.24%
6 MONTHS -0.30%
1 YEAR 68.00%
2 YEAR P.A. 35.60%
3 YEAR P.A. 22.45%
SINCE INCEPTION (TOTAL) 85.88%
INCEPTION DATE DEC 16

Returns as at 31 March 2021.

DISCLAIMER: All figures quoted are net returns after all fees and applicable taxes have been deducted. The information on this webpage has been prepared by Acorn Capital GP Pty Limited (Acorn) and is based on information available to it at the time and no representation is made as to its accuracy, correctness or completeness of the information herein. To the maximum extent permitted by law, none of Acorn, its directors, employees, agents or contractors or any other person accepts any liability for any loss or damage whatsoever arising from or in connection with the use or reliance on this document or its contents. Any forecasts contained in this document reflect the opinion of Acorn and not the Company that is the subject of the document. The forecasts are based on expectations and plans that may not be achieved and are based on assumptions that may not be met. The performance and operations of the Company that is the subject of this document may be influenced by a number of factors, many of which are outside the control of Acorn. No representation or warranty, express or implied, is made by Acorn or any of its directors, officers, employees, advisers or agents that any intentions, expectations or plans will be achieved either totally or partially. In particular, no representation or warranty is made that any particular future milestones or production will be achieved.

SIV Compliant Investments Completed by RAM & Acorn Capital

The Fund has made 11 SIV Compliant VCPE investments since 2017 with 5 of those companies have either listed or been sold via trade sale. Our investments include but not limited to:

IPO Exit (ASX: OGA)

Ocean Grown Abalone Pty Ltd (“OGA”)

OGA is the only wild catch abalone operators of “ranch” style production in Australia. OGA’s unique process delivers a premium product in a sustainable, environmentally friendly way, at a lower cost than land based methods. OGA is currently unique and has a lead time of 5-10 years over any future competitors. Production is now a consistent 1m per week from the initial abitats and will reach 200 tonnes p.a. by FY21.

Status: Listed on the Australian Securities Exchange in November 2017 (ASX: OGA)
Exited Successfully (Acquired)

Genea Pty Ltd (“GENEA”)

Genea is Australia’s 3rd largest IVF provider. Exclusive global distribution with Merck, one of the largest pharmaceutical companies in the world with revenue of USD 40bn. Through significant levels of research and development Genea has developed world-class technology that’s used in over 60 countries and 600 clinics around the world.

Status: Exited – acquired by a consortium comprised of Hong Kong listed Mason Group and Chinese entity WeDoctor
IPO EXIT (ASX: CBR)

Carbon Revolution Pty Ltd (“CBR”)

CR is the world’s leading designer and manufacturer of single piece carbon fibre wheels for the automotive industry. Validation of CarbonRev’s technology had previously been received through a contracts with Ford to provide wheels as an option on the GT supercar and as standard equipment on the Mustang Shelby GTR. Ferrari also announced that its new 488 Pista will offer carbon fibre wheels in March 2018.

Status: Listed on the Australian Securities Exchange in November 2019 (ASX: CBR)
IPO EXIT (ASX: CLU)

Cluey Learning (“Cluey”)

Cluey is an online school student tutorial business. It provides a service that puts structure and digital platform around the informal tutoring market – the typical target is a primary or secondary school student looking for specific subject help who would ordinarily use older students/teachers to provide this service in home.

Status: Listed on the Australian Securities Exchange in December 2020 (ASX:CLU)
IPO EXIT (ASX: CSX)

CleanSpace Respirators (“CleanSpace”)

CleanSpace has reinvented respiratory protective masks. Their product utilise the latest in medical device technology for high protection and performance over traditional healthcare protective respirators. Importantly the intuitive and ergonomic design, makes training and use easy and fast – ensuring comfort and compliance in healthcare settings. Unsurprisingly, the COVID-19 period has seen unprecedented demand for their products.

Status: Listed on the Australian Securities Exchange in October 2020 (ASX:CSX)
EXIT PIPELINE

Innovation Asset Solutions Group (“IAS”)

IAS is a highly innovative service provider in the preservation, repair and decommissioning of assets for the oil & gas, mining, public infrastructure and industrial sectors. IAS is growing rapidly with a list of tier 1 clients and needs to the additional capital to further accelerate this growth. IAS has a strategic alliance with ASX100 Company, Monadelphous Group, a specialist EPCM contractor in onshore and topside assets.

*Calculated to liquidity date, including investments yet to achieve liquidity. Returns are not guaranteed.
Investors should review and consider the risks stated in the information memorandum, including market and liquidity risk.

In the Media

Industry Recognition

“Our Investment Philosophy is built around keeping the investment process simple and transparent and ensuring our clients are at the centre of everything we do.”

Scott Wehl
Founder & Group CEO